Micron-size drug particles:: Common and novel micronization techniques

被引:262
作者
Rasenack, N [1 ]
Müller, BW [1 ]
机构
[1] Univ Kiel, Dept Pharmaceut & Biopharmaceut, D-24118 Kiel, Germany
关键词
micron-size drug; milling techniques; micronization; surface characterization; controlled crystallization; supercritical fluid; in situ micronization; particle engineering;
D O I
10.1081/PDT-120027417
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug powders containing micron-size drug particles are used in several pharmaceutical dosage forms. Many drugs, especially newly developed substances, are poorly water soluble, which limits their oral bioavailability. The dissolution rate can be enhanced by using micronized drugs. Small drug particles are also required in administration forms, which require the drug in micron-size size due to geometric reasons in the organ to be targeted (e.g., drugs for pulmonary use). The common technique for the preparation of micron-size drugs is the mechanical comminution (e.g., by crushing, grinding, and milling) of previously formed larger particles. In spite of the widespread use of this technique, the milling process does not represent the ideal way for the production of small particles because drug substance properties and surface properties are altered in a mainly uncontrolled manner. Thus, techniques that prepare the drug directly in the required particle size are of interest. Because physicochemical drug powder properties are decisive for the manufacturing of a dosage form and for therapeutic success, the characterization of the particle surface and powder properties plays an important role. This article summarizes common and novel techniques for the production of a drug in small particle size. The properties of the resulting products that are obtained by different techniques are characterized and compared.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 99 条
[1]   PREPARATION OF AQUEOUS POLYMERIC NANODISPERSIONS BY A REVERSIBLE SALTING-OUT PROCESS - INFLUENCE OF PROCESS PARAMETERS ON PARTICLE-SIZE [J].
ALLEMANN, E ;
GURNY, R ;
DOELKER, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 87 (1-3) :247-253
[2]  
[Anonymous], ANGEW CHEM
[3]  
AUWETER H, 1996, Patent No. 19637517
[4]   Magnetic properties of cobalt-cluster dispersions generated in an electrochemical cell [J].
Becker, JA ;
Schafer, R ;
Festag, JR ;
Wendorff, JH ;
Hensel, F ;
Pebler, J ;
Quaiser, SA ;
Helbig, W ;
Reetz, MT .
SURFACE REVIEW AND LETTERS, 1996, 3 (01) :1121-1126
[5]   ELECTROCHEMICAL GROWTH OF SUPERPARAMAGNETIC COBALT CLUSTERS [J].
BECKER, JA ;
SCHAFER, R ;
FESTAG, R ;
RULAND, W ;
WENDORFF, JH ;
PEBLER, J ;
QUAISER, SA ;
HELBIG, W ;
REETZ, MT .
JOURNAL OF CHEMICAL PHYSICS, 1995, 103 (07) :2520-2527
[6]   PHYSICOCHEMICAL ASPECTS OF DRUG RELEASE .8. THE RELATION BETWEEN PARTICLE-SIZE AND SURFACE SPECIFIC DISSOLUTION RATE IN AGITATED SUSPENSIONS [J].
BISRAT, M ;
NYSTROM, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 47 (1-3) :223-231
[7]   THE USE OF ISOTHERMAL MICROCALORIMETRY IN THE STUDY OF CHANGES IN CRYSTALLINITY INDUCED DURING THE PROCESSING OF POWDERS [J].
BRIGGNER, LE ;
BUCKTON, G ;
BYSTROM, K ;
DARCY, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 105 (02) :125-135
[8]   THE EFFECT OF THE COMMINUTION TECHNIQUE ON THE SURFACE-ENERGY OF A POWDER [J].
BUCKTON, G ;
CHOULARTON, A ;
BEEZER, AE ;
CHATHAM, SM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 47 (1-3) :121-128
[9]   Characterisation of small changes in the physical properties of powders of significance for dry powder inhaler formulations [J].
Buckton, G .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 26 (01) :17-27
[10]  
CATHREIN E, 1991, Patent No. 0410236